Progression of myeloproliferative neoplasm with BCR::JAK2 fusion to acute leukemia of ambiguous lineage

被引：0

作者：

Edwin Uriel Suárez

Miguel Ángel Piris

Socorro María Rodríguez-Pinilla

Juan F. García

José Luis López-Lorenzo

Javier Cornago-Navascués

Rocío Salgado-Sánchez

Tamara Castaño-Bonilla

Raquel Mata-Serna

Juan M. Alonso-Domínguez

Pilar Llamas

机构：

[1] Health Research Institute-Fundación Jiménez Díaz University Hospital,Department of Hematology

[2] Universidad Autónoma de Madrid,Department of Pathology

[3] Health Research Institute-Fundación Jiménez Díaz University Hospital,Department of Pathology

[4] Universidad Autónoma de Madrid,undefined

[5] MD Anderson Cancer Center,undefined

来源：

Annals of Hematology | 2024年 / 103卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：1797 / 1799

页数：2

共 50 条

[41] Evaluation of the association between the JAK2 46/1 haplotype and myeloproliferative neoplasm in a Korean population
Park, S-G.
Ha, J. S.
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2015, 37 (04) : e91 - e95
[42] JAK2 MUTATIONS IN CHRONIC MYELOPROLIFERATIVE NEOPLASM; TOWARDS THE APPLICATION OF PERSONALIZED TREATMENTS FOR SAUDI PATIENTS
Gari, M.
Al-Sayes, F.
Abuzenadah, A.
Chaudhary, A.
Dallol, A.
Al-Qahtani, M.
Damanhouri, G.
HAEMATOLOGICA, 2012, 97 : 632 - 632
[43] Homologous Recombination of Wild TYPE JAK2, A NOVEL EARLY STEP In the DEVELOPMENT of Myeloproliferative Neoplasm
Vilaine, Mathias
Olcaydu, Damla
Harutyunyan, Ashot
Bergeman, Jonathan
Mourad, Tiab
Ramee, Jean-Francois
Chen, Jian-Min
Kralovics, Robert
Hermouet, Sylvie
BLOOD, 2011, 118 (21) : 1210 - 1210
[44] TWO ROUTES TO LEUKAEMIC TRANSFORMATION FOLLOWING A JAK2 MUTATION-POSITIVE MYELOPROLIFERATIVE NEOPLASM
Beer, P. A.
Delhommeau, F.
LeCouedic, J. P.
Bareford, D.
Kukec, R.
McMullin, M. F.
Harrison, C.
Vannucchi, A.
Vainchenker, W.
Green, A. R.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 421 - 421
[45] Two routes to leukemic transformation after a JAK2 mutation-positive myeloproliferative neoplasm
Beer, Philip A.
Delhommeau, Francois
LeCouedic, Jean-Pierre
Dawson, Mark A.
Chen, Edwin
Bareford, David
Kusec, Rajko
McMullin, Mary Frances
Harrison, Claire N.
Vannucchi, Alessandro M.
Vainchenker, William
Green, Anthony R.
BLOOD, 2010, 115 (14) : 2891 - 2900
[46] Dual targeting of JAK2 and ERK interferes with the myeloproliferative neoplasm clone and enhances therapeutic efficacy
Brkic, Sime
Stivala, Simona
Santopolo, Alice
Szybinski, Jakub
Jungius, Sarah
Passweg, Jakob R.
Tsakiris, Dimitrios
Dirnhofer, Stefan
Hutter, Gregor
Leonards, Katharina
Lischer, Heidi E. L.
Dettmer, Matthias S.
Neel, Benjamin G.
Levine, Ross L.
Meyer, Sara C.
LEUKEMIA, 2021, 35 (10) : 2875 - 2884
[47] Dual targeting of JAK2 and ERK interferes with the myeloproliferative neoplasm clone and enhances therapeutic efficacy
Sime Brkic
Simona Stivala
Alice Santopolo
Jakub Szybinski
Sarah Jungius
Jakob R. Passweg
Dimitrios Tsakiris
Stefan Dirnhofer
Gregor Hutter
Katharina Leonards
Heidi E. L. Lischer
Matthias S. Dettmer
Benjamin G. Neel
Ross L. Levine
Sara C. Meyer
Leukemia, 2021, 35 : 2875 - 2884
[48] JAK2 inhibition has different therapeutic effects according to myeloproliferative neoplasm development in mice
Debeurme, Franck
Lacout, Catherine
Moratal, Claudine
Bagley, Rebecca G.
Vainchenker, William
Adrian, Francisco
Villeval, Jean-Luc
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2015, 19 (11) : 2564 - 2574
[49] Leukemia cutis at onset of acute leukemia of ambiguous lineage
Lopez-Andrade, Bernardo
Lo Riso, Laura
Ramos, Rafael
Cunill, Vanesa
Iglesias, Julio F.
Pastor, Maria Antonia Duran
EJHAEM, 2021, 2 (01): : 11 - 12
[50] ACCELERATION OF BCR-ABL plus LEUKEMIA INDUCED BY DELETION OF JAK2
Grundschober, E.
Hoelbl-Kovacic, A.
Bhagwat, N.
Levine, R.
Sexl, V.
HAEMATOLOGICA, 2014, 99 : 794 - 794

← 1 2 3 4 5 →